Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 5.74 EUR -1.03% Market Closed
Market Cap: 160.7m EUR
Have any thoughts about
Hyloris Pharmaceuticals SA?
Write Note

Wall Street
Price Targets

HYL Price Targets Summary
Hyloris Pharmaceuticals SA

Wall Street analysts forecast HYL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HYL is 12.99 EUR with a low forecast of 5.05 EUR and a high forecast of 18.06 EUR.

Lowest
Price Target
5.05 EUR
12% Downside
Average
Price Target
12.99 EUR
126% Upside
Highest
Price Target
18.06 EUR
215% Upside
Hyloris Pharmaceuticals SA Competitors:
Price Targets
4530
Hisamitsu Pharmaceutical Co Inc
7% Upside
1477
Ocumension Therapeutics
95% Upside
JNJ
Johnson & Johnson
16% Upside
4507
Shionogi & Co Ltd
19% Upside
TARS
Tarsus Pharmaceuticals Inc
37% Upside
KLBF
Kalbe Farma Tbk PT
21% Upside

Revenue
Forecast

Revenue Estimate
Hyloris Pharmaceuticals SA

For the last 5 years the compound annual growth rate for Hyloris Pharmaceuticals SA's revenue is 87%. The projected CAGR for the next 3 years is 180%.

87%
Past Growth
180%
Estimated Growth
Estimates Accuracy
-47%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Hyloris Pharmaceuticals SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Net Income
Forecast

Net Income Estimate
Hyloris Pharmaceuticals SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HYL's stock price target?
Price Target
12.99 EUR

According to Wall Street analysts, the average 1-year price target for HYL is 12.99 EUR with a low forecast of 5.05 EUR and a high forecast of 18.06 EUR.

What is Hyloris Pharmaceuticals SA's Revenue forecast?
Projected CAGR
180%

For the last 5 years the compound annual growth rate for Hyloris Pharmaceuticals SA's revenue is 87%. The projected CAGR for the next 3 years is 180%.

Back to Top